http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IL-261558-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4745
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-10
filingDate 2018-09-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2018-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber IL-261558-A
titleOfInvention N,n-dimethyl-3-[[5-(3-methyl-2-oxo-1-tetrahydropyran-4-yl-imidazo[4,5-c]quinolin-8-yl)-2-pyridyl]oxy]propan-1-amine oxide as atm (ataxia telangiectasia mutated) kinase modulator for treating cancer
priorityDate 2016-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7852
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300711
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID41839
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419545531
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395401
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID472
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID526824
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID451530
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID11920
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID479450
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID403064

Total number of triples: 24.